N-[2-(4-Methylphenyl)Ethyl]-N′-[2-(5-Bromopyridyl)]-Thiourea as a Potent Inhibitor of NNRTI-Resistant and Multidrug-Resistant Human Immunodeficiency Virus Type 1
نویسندگان
چکیده
منابع مشابه
Synthesis of N, N΄3, 4-Dialkylamino-1, 2, 5-Oxadiazoles
N, N΄-3, 4-di(methylamino)-1, 2, 5-oxadiazole (1f) was prepared by dehydration of N, N΄-3, 4-di(methylamino)glyoxime (2f) in aqueous potassium hydroxid at 170-180 ˚C. Under similar conditions N, N΄-3, 4-di(benzylamino)-1, 2, 5-oxadiazole (1c) and N, N΄-3, 4-di(isopropylamino)...
متن کاملQuantification Analysis of Dot Blot Assays for Human Immunodeficiency Virus Type 1 and 2 Antibodies
Objective Dot Blot (DB) assay provides highly specific results, but usually not reliable for quantification of antibody production. The need for a more objective DB assay to provide a better definition of the immune status, against HIV antigens, promoted this study to be done to develop a quantitative DB assay. Material and Methods Dot blot (DB) strips for antibodies directed to human immuno...
متن کاملMaraviroc (Celsentri) for multidrug-resistant human immunodeficiency virus (HIV)-1.
(1) Maraviroc belongs to a new class of antiretroviral drugs designed to block entry of HIV-1 into CD4+ T-cells via the CCR5 coreceptor. It is indicated for combination therapy in treatment-experienced adults infected with CCR5-tropic HIV-1 that is resistant to multiple antiretroviral agents. (2) Results from two randomized controlled trials (RCTs) indicate that in treatment experienced patient...
متن کاملCrystal structure of N-2-tolyl-N'-4-tolyl-thiourea.
lead and mercury poisoning in humans,1 we are currently working on the synthesis of a new series of chelating agents such as N-2-tolyl-N′-4-tolyl-thiourea (Fig. 1). In this paper, we present the crystal structure of (I). It is important to mention that there are only a few structure reports exclusively concerning substituted-thiourea derivatives, which may be due to the difficulty in preparing ...
متن کاملsynthesis of n, n΄3, 4-dialkylamino-1, 2, 5-oxadiazoles
n, n΄-3, 4-di(methylamino)-1, 2, 5-oxadiazole (1f) was prepared by dehydration of n, n΄-3, 4-di(methylamino)glyoxime (2f) in aqueous potassium hydroxid at 170-180 ˚c. under similar conditions n, n΄-3, 4-di(benzylamino)-1, 2, 5-oxadiazole (1c) and n, n΄-3, 4-di(isopropylamino)-1, 2, 5-oxadiazole (1e) were not obtained, but, n, n΄-3, 4-di(ethylamino)-1, 2, 5-oxadiazole (1g) was appeared with smal...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Antiviral Chemistry and Chemotherapy
سال: 2000
ISSN: 2040-2066,2040-2066
DOI: 10.1177/095632020001100205